COMP dishes out nine positive orphan opinions
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's Committee for Orphan Medicinal Products recommended at its June meeting that the European Commission issue nine orphan designations. Four of the positive opinions were for Aptiv Solutions' metreleptin.